Therma Bright's Venowave™ device sees strong demand with Horizon Health doubling its order.

Therma Bright announced that Horizon Health has purchased an additional 100 units of its Venowave™ mobile compression device, doubling their initial order made in March 2026. This follow-up order highlights strong demand for Venowave™ among Horizon's vascular patients, supported by positive clinical feedback and effective distribution channels. Therma Bright expects this to be the foundation for a significant long-term revenue stream as Horizon Health plans to increase order frequency and volume throughout the year. Venowave™ is a compact device designed to improve blood flow and prevent blood clots, reimbursed under Medicare in the U.S., and is gaining traction in vascular care protocols.